Hawley blasts FDA approval of new abortion drug, cites safety and trust concerns
The FDA approved generic mifepristone from Evita Solutions, and Sen. Josh Hawley blasted the agency for regulatory failure and endangering women's health.
The FDA approved generic mifepristone from Evita Solutions, and Sen. Josh Hawley blasted the agency for regulatory failure and endangering women's health.
The National Park Service’s 474 national monuments, memorials, and parks remain reliant on skeleton crews in the wake of the federal government shutdown. Operational capacity of each site’s staff was reduced to an absolute minimum after thousands of employees were furloughed. We had a problem loading this article. Please enable javascript or use a different
Military leaders received blunt orders from War Secretary Pete Hegseth about fitness standards and Trump administration policies at a historic Quantico meeting.
Washington — While President Trump billed the federal law enforcement surge in the nation’s capital as an effort to crack down on violent crime, internal government data obtained by CBS News shows nearly 40% of over 3,500 arrests made since the operation began in early August were strictly immigration-related. The federal government statistics indicate that,
Three Stafford County voters challenge Democrat Stacey Carroll's candidacy, claiming she lives in district 23 rather than district 64 where she filed to run for Virginia House.
Pessimism about the U.S. economy and its direction continues this month — negative ratings have persisted for years — along with net-negative ratings for the U.S. job market, specifically. And in a year that has seen plenty of announcements about AI innovations and implications, there is also plenty of public suspicion that the job market may
President Trump’s suggestion last week that combination childhood vaccines, including the measles, mumps and rubella, or MMR, shot, should be separated marks a sharp break from decades of immunization practice in the United States. “I was shocked,” said Dr. William Moss, executive director of the International Vaccine Access Center at the Johns Hopkins Bloomberg School